Pericardial Patches Market Size & Share, by Product Type (Autologous, Xenograft, Synthetic); Source (Porcine Patch, Bovine Patch, Equine Patch); Application (Cardiovascular Surgery, Dental Surgery, Ophthalmology, Abdominal Surgery); End-user (Hospitals, Ambulatory Care Centers, Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4589
Published Date: Feb 22, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Pericardial Patches Landscape

Edwards Lifesciences Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Visionary Medtech Solutions
Abbott Laboratories
CryoLife, Inc.
LeMaitre Vascular, Inc.
Neovasc, Inc.
FOC Medical
W. L. Gore & Associates, Inc.
Baxter International Inc.
Collagen Solutions Plc

Browse Key Market Insights with Data Illustration:

Pericardial Patches Market Size, Growth Outlook 2023-2033

In the News

Abbott Laboratories' HEARTMATE 3 heart pump can prolong life beyond five years in patients with limited therapeutic options.
Edwards Lifesciences Corporation has announced that its PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation and can improve clinicians' ability to provide positive outcomes for patients with both MR and TR through a single delivery system.

Frequently Asked Questions (FAQ)

The rise in the prevalence of chronic diseases, improvements in pericardial patch manufacturing and sterilization, and increased use of soft tissue patches in surgeries are the major factors driving the growth of the pericardial patches market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033

Insufficient supply of grafts and increased risk of infections along with the high costs of medical products are estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott Laboratories, CryoLife, Inc., LeMaitre Vascular, Inc., Neovasc, Inc., FOC Medical, W. L. Gore & Associates, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, source, application, end user, and by region.

The cardiovascular surgery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Pericardial Patches Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the pericardial patches market?

What would be the CAGR of pericardial patches market over the forecast period?

What are the challenges affecting the pericardial patches market growth?

Which region will provide more business opportunities for growth of pericardial patches market in future?

Who are the major players dominating the pericardial patches market?

How are the company profiles selected?

What are the segments in the pericardial patches market?

Which segment captures the largest market size in application segment in the pericardial patches market?